HOME - Clinical cases - Oral pathology
 
 
01 April 2021

Gnathodiaphyseal dysplasia: review of the literature and treatment of two clinical cases

Authors:A. Rossi, T. Terenzio, L. Moneghini, D. Scarnò, M. Vitali, S. Giovannini


The aim of this paper is to perform a literature review regarding the Gnathodiaphyseal Dysplasia (GDD), describing two clinical cases. 

MATERIALS AND METHODS
A literature search on PubMed and Scopus was carried out using the following keywords (“Gnathodiaphyseal Dysplasia”, “anoctamin 5”, “jawbone disease”, “fibro-osseous lesion”).

RESULTS AND CONCLUSIONS
Gnathodiaphyseal Dysplasia is a rare autosomal dominant syndrome caused by mutation in the ANO 5 gene. The most frequent clinical signs are: maxillary fibro-osseous lesions, bone fragility, diaphyseal cortical thickening and bowing of long bones. However, there is great variability between patients. Genetic screening is at present the only reliable diagnostic tool. Gnathodiaphyseal Dysplasia is a rare genetic syndrome that requires in-depth study and a multidisciplinary team.


Related articles

This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


This peer-reviewed oral pathology article summarizes clinical evidence from BMC oral health (2024). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


Read more

New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.


(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C


(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will


As the University of Colorado School of Dental Medicine celebrates the graduating DDS Class of 2025, we are proud to recognize the students and faculty members whose exceptional de


This peer-reviewed oral surgery article summarizes clinical evidence from International journal of oral and maxillofacial surgery (2026). It focuses on findings that may help dental professionals...


 
 
 
 

 
 
 
 

Most popular

 
 

Events